Skip to content

DocGo DCGO Common Stock Shares Outstanding

Common Stock Shares Outstanding at other companies

Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$13.12M+51.2%
SRT
Strata Critical Medical, Inc. Class A Common StockSRTA
$10.42M
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's common stock shares outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's common stock shares outstanding?
DocGo (DCGO) reported common stock shares outstanding of $0 in Q1 2026.
How has DocGo's common stock shares outstanding changed year-over-year?
DocGo's common stock shares outstanding decreased by 100.0% year-over-year, from $830.31K to $0.
What is the long-term trend for DocGo's common stock shares outstanding?
Over 5 years (2020 to 2025), DocGo's common stock shares outstanding has grown at a -100.0% compound annual growth rate (CAGR), from $8.13M to $0.
What does common stock shares outstanding mean?
This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.